🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to perform a comparison of the efficacy and safety...
Status
Completed
Location
Department of Diabetes and Endocrinology at Sindh Government Hospital New Karachi & Dr. Riasat Medical Center Allah Wala Town, Karachi, Pakistan
Start Date
2020-07-01
Trial ID
NCT05359432
Treatments Being Tested
This mechanistic study is designed to investigate the effect of vildaglipti...
Status
Completed
Location
Novartis
Start Date
2006-09
Trial ID
NCT00390520
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of a fixed...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-09
Trial ID
NCT00382096
Treatments Being Tested
This study will evaluate the pharmacokinetics of vildagliptin and its metab...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-07
Trial ID
NCT00567047
Treatments Being Tested
Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Status
Unknown
Location
Kurume University Hospital
Start Date
2015-08
Trial ID
NCT02528019
Treatments Being Tested
Despite advances in diabetes management, many patients with type 2 diabetes...
Status
Completed
Location
Department of endocrinology, FAH-SYSU
Start Date
2019-05-01
Trial ID
NCT03958591
Primary Objective: To compare the clinical efficacy of gemigliptin and vil...
Status
Completed
Location
Investigational Site 03
Start Date
2014-12
Trial ID
NCT02343926
Treatments Being Tested
This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-10
Trial ID
NCT00572650
Treatments Being Tested
The purpose of this study was to determine whether the initiation of a vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03-30
Trial ID
NCT01528254
Treatments Being Tested
This is a 28-week extension to a study of the safety and effectiveness of t...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-10
Trial ID
NCT00138541
Treatments Being Tested